Leveraging Illumina’s leading sequencing technology and informatics tools alongside Nvidia’s lea Illumina, Inc. (NASDAQ: ILMN) ("Illumina" or the "company") today announced unaudited ...
Illumina, Inc. (NASDAQ: ILMN), a global leader in genomic sequencing and analysis, today announced it is collaborating with NVIDIA to advance technology platforms for the analysis and ...
Illumina and Regeneron are taking stakes in ... of Health’s All of Us million-person program and other massive DNA sequencing projects. The companies—supported by more than a dozen major ...
This important study reveals a role for IκBα in the regulation of embryonic stem cell pluripotency. The solid data in mouse embryonic stem cells include separation of function mutations in IκBα to ...
A century ago, physics had its Darwinian moment — a change in perspective that was as consequential for the physical sciences as the theory of evolution by natural selection was for biology ...
In vivo perturbations and single-cell RNA-seq reveal cell-type-specific STAT1-IFNg signaling in regulation of trained immunity in tissue-resident immune cells.
The purified DNA is fully digestible with all restriction enzymes tested, and is completely compatible with manual or automated sequencing to achieve 95-100% accuracy. BAC DNA could be purified ...
Natural product synthesis aims to prepare a complex target molecule such that the product is analytically identical to the naturally occurring compound, termed a natural product. It is used for ...